METALLOPROTEASE ADAMTS-13

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Plasmatic ADAMTS-13 metalloprotease and von Willebrand factor in children with cyanotic congenital heart disease

Changes in plasma von Willebrand factor concentration (VWF:Ag) and ADAMTS-13 activity (the metalloprotease that cleaves VWF physiologically) have been reported in several cardiovascular disorders with prognostic implications. We therefore determined the level of these proteins in the plasma of children with cyanotic congenital heart disease (CCHD) undergoing surgical treatment. Forty-eight chil...

متن کامل

ADAMTS-13 gene expression in antiphospholipid syndrome Antifosfolipid sendromunda ADAMTS-13 gen ekspresyonu

Veysel Sabri Hançer1, Reyhan Diz Küçükkaya2, Ayşegül Topal-Sarıkaya3 1Department of Medical Biology and Genetics, Faculty of Medicine, İstanbul Bilim University, İstanbul, Turkey 2Department of Internal Medicine, Division of Hematology, Faculty of Medicine, İstanbul Bilim University, İstanbul, Turkey 3Department of Molecular Biology and Genetics, Faculty of Science, İstanbul University, İstanbu...

متن کامل

Recombinant ADAMTS 13 Attenuates Brain Injury After Intracerebral Hemorrhage.

BACKGROUND AND PURPOSE Inflammatory responses and blood-brain barrier (BBB) dysfunction play important roles in brain injury after intracerebral hemorrhage (ICH). The metalloprotease ADAMTS 13 (a disintegrin and metalloprotease with thrombospondin type I motif, member 13) was shown to limit inflammatory responses through its proteolytic effects on von Willebrand factor. In the present study, we...

متن کامل

Conformational quiescence of ADAMTS‐13 prevents proteolytic promiscuity

Essentials Recently, ADAMTS-13 has been shown to undergo substrate induced conformation activation. Conformational quiescence of ADAMTS-13 may serve to prevent off-target proteolysis in plasma. Conformationally active ADAMTS-13 variants are capable of proteolysing the Aα chain of fibrinogen. This should be considered as ADAMTS-13 variants are developed as potential therapeutic agents. Click to ...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Russian journal of hematology and transfusiology

سال: 2019

ISSN: 2411-3042,0234-5730

DOI: 10.35754/0234-5730-2019-64-4-471-482